Page last updated: 2024-10-26

dipyridamole and Agammaglobulinemia

dipyridamole has been researched along with Agammaglobulinemia in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Agammaglobulinemia: An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McKenzie, PE1
Taylor, AE1
Woodroffe, AJ1
Seymour, AE1
Chan, YL1
Clarkson, AR1
Shah, T1
Simpson, RJ1
Webster, AD1
Peters, TJ1

Other Studies

2 other studies available for dipyridamole and Agammaglobulinemia

ArticleYear
Plasmapheresis in glomerulonephritis.
    Clinical nephrology, 1979, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Agammaglobulinemia; Anti-Glomerular Basement Membrane Disease; Complement System

1979
Binding of adenosine and receptor-specific analogues to lymphocytes from control subjects and patients with common variable immunodeficiency.
    Clinical and experimental immunology, 1987, Volume: 69, Issue:2

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adult; Agammaglobulinemia; Dipyridamole; Erythrocytes;

1987